Skip to main content

Table 3 Antibiotic susceptibility rates according to the occurrence of severe complications attributable to viridans streptococcal bacteremia

From: Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children

Antibiotics

All patients* (n=201)

Without complications (n=175)

With complications (n=26)

p-value

Penicillin

79/201 (39.3)

70/175 (40.0)

9/26 (34.6)

0.600

Cefotaxime†

166/200 (83.0)

142/174 (81.6)

24/26 (92.3)

0.263

Cefepime‡

159/199 (79.9)

136/173 (78.6)

23/26 (88.5)

0.243

Vancomycin

201/201 (100.0)

175/175 (100.0)

26/26 (100.0)

NA

Linezolid

200/201 (99.5)

174/175 (99.4)

26/26 (100.0)

1.000

Clindamycin

172/201 (85.6)

151/175 (86.3)

21/26 (80.8)

0.548

Erythromycin

99/201 (49.3)

86/175 (49.1)

13/26 (50.0)

0.935

  1. Data are No. (%) of cases.
  2. NA not available.
  3. *Antibiotic susceptibility tests were performed in 201 patients (175 without severe complications, 26 with severe complications).
  4. †Antibiotic susceptibility tests were performed in 200 patients (174 without severe complications, 26 with severe complications).
  5. ‡Antibiotic susceptibility tests were performed in 199 patients (173 without severe complications, 26 with severe complications).